[监狱中的普雷加巴林:对全科医生的建议]
Jalel Araiedh1,2, Didier Delessert2, Yasser Khazaal1
1Service de médecine des addictions, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Revue medicale suisse
|November 21, 2024
概括
滥用普雷加巴林 (Lyrica) 是很常见的,特别是在监狱里. 一个包含指示澄清,加巴丁辅助戒断,替代性症状管理和成咨询的四方策略可以有效地解决这个问题.
科学领域:
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
- 犯罪学 犯罪学
背景情况:
- 滥用普雷加巴林 (Lyrica) 是一个越来越令人担忧的问题,特别是影响弱势群体.
- 监狱环境带来了独特的挑战,因为pregabalin滥用和贩运的普遍性.
- 解决pregabalin滥用问题需要采用适合特定环境的多方面的方法.
研究的目的:
- 概述在监狱系统内滥用普雷加巴林的范围.
- 提出一个实用的,四轴战略,用于管理pregabalin滥用和贩运.
- 为医疗保健提供者和处理这个问题的惩戒设施提供解决方案.
主要方法:
- 澄清适用于处方普雷加巴林的适当医疗适应症.
- 使用 gabapentin 作为支持性药物用于普雷加巴林戒断.
- 对神经病痛和等疾病实施替代药理或非药理治疗.
- 为受影响的个人提供专门的成咨询服务.
主要成果:
- 拟议的战略为医疗保健专业人员在惩戒机构提供了一个结构化的框架.
- 它涉及pregabalin依赖的生理和心理方面.
- 成功实施可以导致监狱内的pregabalin滥用和贩运减少.
结论:
- 一个全面的战略是必要的,以打击在监狱中滥用普雷加巴林.
- 四轴方法为干预提供了一个实用和有效的干预模式.
- 综合护理,包括医疗管理和成咨询,对于成功的结果至关重要.
相关概念视频
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
333
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
333
01:20Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
251
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
251
01:25Analgesia and Pain Management
513
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
513
01:14CNS Depressants: Barbiturates and Benzodiazepines
224
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
224
01:14Antiepileptic Drugs: Glutamate Antagonists
283
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
283